Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takemasa Tsuji

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
International Immunology|May 17, 2003
Differential regulation of VLA-2 expression on Th1 and Th2 cells: a novel marker for the classification of Th subsetsKotaro Sasaki, Takemasa Tsuji, Takafumi Jinushi, et al.
Biochemical and Biophysical Research Communications|January 22, 2004
IFN-gamma-induced SOCS-1 regulates STAT6-dependent eotaxin production triggered by IL-4 and TNF-alphaTakeshi Sato, Rumina Saito, Takafumi Jinushi, et al.
Immunology Letters|August 28, 2003
Functional expression of the TrkC gene, encoding a high affinity receptor for NT-3, in antigen-specific T helper type 2 (Th2) cellsMasashi Sekimoto, Takemasa Tsuji, Jyunko Matsuzaki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 20, 2012
Heat shock protein 90-mediated peptide-selective presentation of cytosolic tumor antigen for direct recognition of tumors by CD4(+) T cellsTakemasa Tsuji, Junko Matsuzaki, Otavia L Caballero, et al.
Cancer Science|October 15, 2003
Critical role of the Th1/Tc1 circuit for the generation of tumor-specific CTL during tumor eradication in vivo by Th1-cell therapyKenji Chamoto, Akemi Kosaka, Takemasa Tsuji, et al.
Blood|November 8, 2007
Induction of regulatory T cell-resistant helper CD4+ T cells by bacterial vectorHiroyoshi Nishikawa, Takemasa Tsuji, Elke Jäger, et al.
Cancer Immunology Research|April 30, 2014
Effect of Montanide and poly-ICLC adjuvant on human self/tumor antigen-specific CD4+ T cells in phase I overlapping long peptide vaccine trialTakemasa Tsuji, Paul Sabbatini, Achim A Jungbluth, et al.
Oncoimmunology|May 10, 2019
Neoantigens retention in patient derived xenograft models mediates autologous T cells activation in ovarian cancerMuzamil Yaqub Want, Anna Konstorum, Ruea-Yea Huang, et al.
Scientific Reports|October 9, 2015
Direct tumor recognition by a human CD4(+) T-cell subset potently mediates tumor growth inhibition and orchestrates anti-tumor immune responsesJunko Matsuzaki, Takemasa Tsuji, Immanuel F Luescher, et al.
Cancer Research|February 20, 2004
Generation and targeting of human tumor-specific Tc1 and Th1 cells transduced with a lentivirus containing a chimeric immunoglobulin T-cell receptorHiroshi Gyobu, Takemasa Tsuji, Yoshinori Suzuki, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
International Immunology|May 17, 2003
Differential regulation of VLA-2 expression on Th1 and Th2 cells: a novel marker for the classification of Th subsetsKotaro Sasaki, Takemasa Tsuji, Takafumi Jinushi, et al.
Biochemical and Biophysical Research Communications|January 22, 2004
IFN-gamma-induced SOCS-1 regulates STAT6-dependent eotaxin production triggered by IL-4 and TNF-alphaTakeshi Sato, Rumina Saito, Takafumi Jinushi, et al.
Immunology Letters|August 28, 2003
Functional expression of the TrkC gene, encoding a high affinity receptor for NT-3, in antigen-specific T helper type 2 (Th2) cellsMasashi Sekimoto, Takemasa Tsuji, Jyunko Matsuzaki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 20, 2012
Heat shock protein 90-mediated peptide-selective presentation of cytosolic tumor antigen for direct recognition of tumors by CD4(+) T cellsTakemasa Tsuji, Junko Matsuzaki, Otavia L Caballero, et al.
Cancer Science|October 15, 2003
Critical role of the Th1/Tc1 circuit for the generation of tumor-specific CTL during tumor eradication in vivo by Th1-cell therapyKenji Chamoto, Akemi Kosaka, Takemasa Tsuji, et al.
Blood|November 8, 2007
Induction of regulatory T cell-resistant helper CD4+ T cells by bacterial vectorHiroyoshi Nishikawa, Takemasa Tsuji, Elke Jäger, et al.
Cancer Immunology Research|April 30, 2014
Effect of Montanide and poly-ICLC adjuvant on human self/tumor antigen-specific CD4+ T cells in phase I overlapping long peptide vaccine trialTakemasa Tsuji, Paul Sabbatini, Achim A Jungbluth, et al.
Oncoimmunology|May 10, 2019
Neoantigens retention in patient derived xenograft models mediates autologous T cells activation in ovarian cancerMuzamil Yaqub Want, Anna Konstorum, Ruea-Yea Huang, et al.
Scientific Reports|October 9, 2015
Direct tumor recognition by a human CD4(+) T-cell subset potently mediates tumor growth inhibition and orchestrates anti-tumor immune responsesJunko Matsuzaki, Takemasa Tsuji, Immanuel F Luescher, et al.
Cancer Research|February 20, 2004
Generation and targeting of human tumor-specific Tc1 and Th1 cells transduced with a lentivirus containing a chimeric immunoglobulin T-cell receptorHiroshi Gyobu, Takemasa Tsuji, Yoshinori Suzuki, et al.
Pageof 6